Flucloxacillin vs diclofenac in volunteers with successful sugammadex reversal of rocuronium- or vecuronium-induced neuromuscular blockade

Trial Profile

Flucloxacillin vs diclofenac in volunteers with successful sugammadex reversal of rocuronium- or vecuronium-induced neuromuscular blockade

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Mar 2012

At a glance

  • Drugs Diclofenac; Flucloxacillin; Rocuronium bromide; Sugammadex; Vecuronium bromide
  • Indications Bacterial infections; Pain
  • Focus Adverse reactions
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 01 Mar 2012 Results published in Clinical Drug Investigation.
    • 22 Feb 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top